Opaleye Management Inc. 13D and 13G filings for Adamas Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-26 11:00 am Sale |
2021-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Opaleye Management Inc. | 0 0.000% |
-1,487,800 (Position Closed) |
Filing |
| 2021-02-12 5:20 pm Purchase |
2020-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Opaleye Management Inc. | 1,487,800 5.220% |
61,800 (+4.33%) |
Filing |
| 2020-08-21 5:15 pm Purchase |
2020-08-11 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Opaleye Management Inc. | 1,426,000 5.040% |
1,426,000 (New Position) |
Filing |